Chauveau et al., 2017 - Google Patents
Skin prick tests and specific IgE in 10‐year‐old children: agreement and association with allergic diseasesChauveau et al., 2017
View HTML- Document ID
- 12697458534078766124
- Author
- Chauveau A
- Dalphin M
- Mauny F
- Kaulek V
- Schmausser‐Hechfellner E
- Renz H
- Riedler J
- Pekkanen J
- Karvonen A
- Lauener R
- Roduit C
- Vuitton D
- Von Mutius E
- Dalphin J
- PASTURE Study Group
- Hyvärinen A
- Kirjavainen P
- Remes S
- Roponen M
- Braun‐Fahrländer C
- Frei R
- Lauener R
- Depner M
- Ege M
- Genuneit J
- Illi S
- Kabesch M
- Loss G
- Pfefferle P
- Schaub B
- Doekes G
- Publication year
- Publication venue
- Allergy
External Links
Snippet
Background Accurate assessment of atopic sensitization is pivotal to clinical practice and research. Skin prick test (SPT) and specific IgE (sIgE) are often used interchangeably. Some studies have suggested a disagreement between these two methods, and little is known …
- 238000010181 skin prick test 0 title abstract description 106
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/686—Anti-idiotype
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chauveau et al. | Skin prick tests and specific IgE in 10‐year‐old children: agreement and association with allergic diseases | |
| Santos et al. | Predictive factors for the persistence of cow’s milk allergy | |
| Wright et al. | Component‐resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness | |
| Roberts et al. | A new framework for the interpretation of IgE sensitization tests | |
| Schoos et al. | Disagreement between skin prick test and specific IgE in young children | |
| Werfel et al. | Role of food allergy in atopic dermatitis | |
| Wegienka et al. | Lifetime dog and cat exposure and dog‐and cat‐specific sensitization at age 18 years | |
| Glaumann et al. | Basophil allergen threshold sensitivity, CD‐sens, IgE‐sensitization and DBPCFC in peanut‐sensitized children | |
| Eller et al. | Food allergy and food sensitization in early childhood: results from the DARC cohort | |
| Muthu et al. | Utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis: A systematic review and diagnostic test accuracy meta‐analysis | |
| Kilpeläinen et al. | Childhood farm environment and asthma and sensitization in young adulthood | |
| Ballardini et al. | ImmunoCAPTM Phadiatop® Infant–a new blood test for detecting IgE sensitisation in children at 2 years of age | |
| Aichbhaumik et al. | Prenatal exposure to household pets influences fetal immunoglobulin E production | |
| Lakwijk et al. | Validation of a screening questionnaire for atopy with serum IgE tests in a population of pregnant Dutch women | |
| Di Fraia et al. | A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: a validation study | |
| Julge et al. | Development of allergy and IgE antibodies during the first five years of life in Estonian children | |
| Agabriel et al. | Ara h 2 and Ara h 6 sensitization predicts peanut allergy in Mediterranean pediatric patients | |
| Bodtger et al. | Rhinitis symptoms and IgE sensitization as risk factors for development of later allergic rhinitis in adults | |
| Cipriani et al. | Early molecular biomarkers predicting the evolution of allergic rhinitis and its comorbidities: A longitudinal multicenter study of a patient cohort | |
| Malmberg et al. | Cow's milk allergy as a predictor of bronchial hyperresponsiveness and airway inflammation at school age | |
| Sacco et al. | Growth curves of “normal” serum total IgE levels throughout childhood: a quantile analysis in a birth cohort | |
| Hansen et al. | The natural course of cow’s milk allergy and the development of atopic diseases into adulthood | |
| Nwaru et al. | Serum vitamin E concentrations at 1 year and risk of atopy, atopic dermatitis, wheezing, and asthma in childhood: the PASTURE study | |
| Chauveau et al. | Disagreement between skin prick tests and specific IgE in early childhood | |
| Esaki et al. | Levels of immunoglobulin E specific to the major food allergen and chemokine (C‐C motif) ligand (CCL) 17/thymus and activation regulated chemokine and CCL 22/macrophage‐derived chemokine in infantile atopic dermatitis on I shigaki I sland |